• Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration
    Apr 28 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Jeffrey Heier of Ophthalmic Consultants of Boston discusses ‘Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration,' published in the March/April 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Heier discuss the clinical use of home optical coherence tomography (OCT) for managing patients with neovascular age-related macular degeneration (AMD). Dr. Heier shares study findings showing that 42% of patients would have had a different treatment decision based on home OCT monitoring, highlighting the technology’s potential to catch fluid recurrence earlier and safely extend treatment intervals, from an average of 8 weeks to over 15 weeks. They also discuss the high usability of home OCT devices, with over 95% of patients successfully setting up and using the device independently. The conversation underscores how home OCT can improve outcomes, reduce undertreatment, and drive meaningful cost savings.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

    Show More Show Less
    11 mins
  • Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use
    Apr 28 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. John Kitchens of Retina Associates of Kentucky discusses 'Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use,' published in the March/April 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Kitchens discuss a complex case of tractional retinal detachment initially thought to be a complication of diabetes. Despite good glycemic control (A1c 6.7), further investigation revealed the underlying cause was severe vascular damage from methamphetamine use, not diabetes. Dr. Kitchens shares insights on the importance of thorough history-taking, recognizing when clinical findings don’t align with expectations, and the value of timely surgery in achieving favorable outcomes even in complex cases.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

    Show More Show Less
    11 mins
  • Multifocal Torpedo Maculopathy Complicated by Choroidal Neovascularization
    Apr 17 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Matthew G.J. Trese of Associated Retina Consultants of Royal Oak, MI, discusses ‘Multifocal Torpedo Maculopathy Complicated by Choroidal Neovascularization,’ published in the March/April 2025 issues of JVRD.

    Host Dr. Timothy Murray and Dr. Trese discuss the rare and complex presentation of torpedo maculopathy in a pediatric patient, the evolving role of imaging and anti-VEGF therapy in young children, and the value of case reports in expanding our understanding of this condition.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

    Show More Show Less
    10 mins
  • Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema
    Apr 17 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Katherine E. Talcott of the Cole Eye Institute at the Cleveland Clinic discusses ‘Predictors of Vision Loss After Lapse in Antivascular Endothelial Growth Factor Treatment in Patients With Diabetic Macular Edema,’ published in the March/April 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Talcott discuss the clinical implications of treatment lapses in patients with diabetic macular edema and the importance of identifying individuals at higher risk for vision loss. Dr. Talcott highlights key predictors of vision loss, such as longer lapses, diabetic foot disease, and Medicaid insurance, and discusses how these insights can guide personalized care, improve patient counseling, and support proactive interventions to preserve vision in this vulnerable population.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

    Show More Show Less
    11 mins
  • So Many Injections, So Much Waste: Understanding the Environmental Impact of Intravitreal Injections
    Apr 16 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Geoff G. Emerson of Retina Consultants of Minnesota discusses ‘So Many Injections, So Much Waste: Understanding the Environmental Impact of Intravitreal Injections,’ published in the March/April 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Emerson discuss the significant environmental impact of intravitreal (IVT) injections, highlighting the waste generated from packaging, single-use materials, and patient travel. Actionable strategies are examined, such as adopting reusable materials, electronic instructions, and multidose packaging, to reduce the carbon footprint while maintaining high standards of patient care.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

    Show More Show Less
    11 mins
  • Confirmatory Cytopathology and Potential Impact on the Predictive Value of Gene Expression Profiling in Patients With Uveal Melanoma
    Apr 16 2025

    On this episode of the JVRD Author's Forum podcast, Dr. Ivana K. Kim of Massachusetts Eye and Ear Infirmary in Boston, discusses ‘Confirmatory Cytopathology and Potential Impact on the Predictive Value of Gene Expression Profiling in Patients With Uveal Melanoma,' published in the March/April 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Kim discuss research on the utility of gene expression profiling (GEP) in diagnosing uveal melanoma, particularly in cases where cytopathology results are non-diagnostic. The study found that even in small tumors where cytopathology may not be practical, GEP alone can still provide valuable prognostic information, making it a reliable tool for clinical decision-making.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

    Show More Show Less
    12 mins
  • The Economics of Emergency Retinal Surgery and Declining Access to Care
    Feb 14 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. John Thompson, JVRD associate editor-in-chief, discusses ‘The Economics of Emergency Retinal Surgery and Declining Access to Care,’ published in the January/February 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Thompson discuss 5 manuscripts published in JVRD that evaluate the economics of retina care and portend an impending crisis for access to emergency surgical retinal care. The research shows that hospitals and surgery centers are losing money on retinal detachment repair, leading many to limit emergency cases. As a result, more patients are being funneled to academic centers, which can create barriers to timely care. Drs. Murray and Thompson explore the increasing reliance on academic centers for emergency cases and the need for policy changes to maintain high-quality retinal care.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.


    Show More Show Less
    11 mins
  • Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021
    Feb 14 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Ron Adelman, consultant and chair of ophthalmology at Mayo Clinic, Florida, discusses ‘Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021,’ published in the January/February 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Adelman examine more than two decades of Medicare reimbursement trends for vitreoretinal procedures. Drawing from a comprehensive 21-year analysis, they discuss how increasing procedure volumes—especially intravitreal injections—have coincided with significant declines in inflation-adjusted reimbursements. Dr. Adelman explains how treatment advances, such as intravitreal injections for diabetic retinopathy and age-related macular degeneration (AMD), have led to decreased use of more invasive procedures, such as cryotherapy and laser, significantly altering the balance of in-office treatments and surgical procedures. He also highlights the growing challenges in accessing operating rooms and the broader implications of diminishing reimbursement for patient care and physician recruitment in the field.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.


    Show More Show Less
    12 mins